K141810 · Becton, Dickinson and Company · MDB · Dec 10, 2014 · Microbiology
Device Facts
Record ID
K141810
Device Name
BD BACTEC PLUS ANAEROBIC/F (PLASTIC)
Applicant
Becton, Dickinson and Company
Product Code
MDB · Microbiology
Decision Date
Dec 10, 2014
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 866.2560
Device Class
Class 1
Indications for Use
The BD BACTEC Plus Anaerobic/F medium is used in a qualitative procedure for the anaerobic culture and recovery of microorganisms (bacteria) from blood. The principal use of this medium is with the BD BACTEC fluorescent series instruments.
Device Story
Device consists of anaerobic culture medium in a multilayer polycarbonate/nylon/polycarbonate plastic bottle; contains soybean casein digest broth and antimicrobial-adsorbing resins. Used in clinical laboratories; operated by trained laboratory personnel. Sample (blood) inoculated into vial; vial inserted into BD BACTEC fluorescent series instrument. Instrument performs automated incubation and agitation; monitors chemical sensor via fluorescence every 10 minutes. Sensor fluorescence increases proportionally to CO2 production from microbial growth. Instrument output provides presumptive positive/negative detection of viable microorganisms. Enables rapid identification of bacteremia; assists clinicians in diagnosing bloodstream infections and guiding antimicrobial therapy.
Clinical Evidence
No clinical data. Evidence consists of seeded internal analytical studies comparing plastic vials to glass predicate. Studies evaluated 528 paired sets across three lots and four instruments. Primary endpoints: Time to Detection (median 16.696h vs 16.773h), Percent Recovery (10-100 CFU/vial), and False Positive/Negative rates. Results showed no statistically significant differences between plastic and glass vials. Antimicrobial neutralization capability was confirmed for common antibiotics.
Technological Characteristics
Plastic vial containing 30 mL enriched soybean-casein digest broth and SPS anticoagulant. Detection via chemical sensor in silicon rubber base (BCP and red dye). Continuous monitoring of CO2-induced fluorescence. Dimensions: 5.0 inches height. Compatible with BACTEC fluorescent series instruments. Sterilization method not specified. Software-based detection algorithms resident in instrument microprocessor.
Indications for Use
Indicated for the anaerobic culture and recovery of bacteria from human blood samples (3-10 mL) using BD BACTEC fluorescent series instruments.
Regulatory Classification
Identification
A microbial growth monitor is a device intended for medical purposes that measures the concentration of bacteria suspended in a liquid medium by measuring changes in light scattering properties, optical density, electrical impedance, or by making direct bacterial counts. The device aids in the diagnosis of disease caused by pathogenic microorganisms.
{0}
1
# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION MEMORANDUM ASSAY AND INSTRUMENT COMBINATION TEMPLATE
A. 510(k) Number:
k141810
B. Purpose for Submission:
To obtain a substantial equivalence determination for a premarket notification for the BD BACTEC Plus Anaerobic/F (plastic) blood culture medium
C. Measurand:
Anaerobic microorganisms from blood
D. Type of Test:
Liquid culture medium for recovery of microorganisms from blood using fluorescent technology to detect the increased $\mathrm{CO}_{2}$ produced by the growth of microorganisms
E. Applicant:
Becton, Dickinson and Company
F. Proprietary and Established Names:
BD BACTEC Plus Anaerobic/F (plastic)
G. Regulatory Information:
1. Regulation section:
21 CFR 866.2560 Microbial Growth Monitor
2. Classification:
Class I
3. Product code:
MDB System, Blood Culture
4. Panel:
{1}
83 Microbiology
H. Intended Use:
1. Intended use(s):
The BD BACTEC Plus Anaerobic/F medium is used in a qualitative procedure for the anaerobic culture and recovery of microorganisms (bacteria and yeast) from blood. The principal use of this medium is with the BD BACTEC fluorescent series instruments.
2. Indication(s) for use:
The BD BACTEC Plus Anaerobic/F medium is used in a qualitative procedure for the anaerobic culture and recovery of microorganisms (bacteria and yeast) from blood. The principal use of this medium is with the BD BACTEC fluorescent series instruments.
3. Special conditions for use statement(s):
Prescription use
4. Special instrument requirements:
BACTEC fluorescent series instruments BACTEC FX, FX40, BACTEC 9240, and BACTEC 9050 were evaluated using software versions listed below:
| Instrument | Software Version |
| --- | --- |
| BACTEC FX | 4.30A |
| BACTEC 9240 | 4.95A |
| BACTEC 9050 | 2.01A2, 2.00B1, 2.00B2 |
| BACTEC FX40 | 1.10C |
I. Device Description:
The blood sample to be tested is inoculated into one or more vials which are inserted into the BACTEC fluorescent series instrument for incubation and periodic reading. Each vial contains a chemical sensor which can detect increases in $\mathrm{CO}_{2}$ produced by the growth of microorganisms. The sensor is monitored by the instrument every ten minutes for an increase in its fluorescence, which is proportional to the amount of $\mathrm{CO}_{2}$ present. A positive reading indicates the presumptive presence of viable microorganisms in the vial. Detection is limited to microorganisms that will grow in a particular type of medium.
J. Substantial Equivalence Information:
1. Predicate device name(s):
BD BACTEC Plus Anaerobic/F (glass)
{2}
2. Predicate 510(k) number(s):
k921133
3. Comparison with predicate:
| Similarities | | |
| --- | --- | --- |
| Item | Device | Predicate |
| Intended Use | Qualitative anaerobic culture and recovery of microorganisms from blood, with the BD BACTEC fluorescent series instrument | Same |
| Sample Type | Human blood | Same |
| Sample Volume | 3- 10 mL | Same |
| Instrument | BD BACTEC fluorescent series | Same |
| Detection Technology | Continuous monitoring; measurement of CO2 increase; resins for absorption of antimicrobials; rocking agitation parameters | Same |
| Incubation | 35°C (± 1.5°C) up to 120 hours | Same |
| Differences | | |
| --- | --- | --- |
| Item | Device | Predicate |
| Vial Material | Plastic | Glass |
| Vial Weight | Lighter than glass | - |
| Vial Height | 5.0 inches | 5.6 inches |
| Growth Medium | 30 mL enriched soybean-casein digest broth | 25 mL enriched soybean-casein digest broth |
| Sensor Adhesion Promoter | Yes | N/A |
| Vial Sensor | 2.6 gram per vial, specific for the plastic vial geometry | 1.75 gram per vial |
| Indicator | BCP- 2.5mg per gram of sensor Red dye- 1.54mg per gram of sensor | BCP- 1mg per gram of sensor Red dye- 1.09mg per gram of sensor |
{3}
4
K. Standard/Guidance Document Referenced (if applicable):
Not applicable
L. Test Principle:
The BD BACTEC Plus Anaerobic/F medium is an enriched soybean- casein digest broth, with each vial containing 30 mL of broth. Sodium polyanetholesulfonate (SPS) is added to the medium as an anticoagulant that inhibits bacteriocidal activities in the blood. The concentration of SPS has been optimized to accommodate blood volumes of up to 10mL per vial.
Each BD BACTEC Plus Anaerobic/F blood culture medium vial contains a chemical sensor in a silicon rubber base that can detect increases in CO₂ produced by the growth of microorganisms. Three to 10mL of blood is inoculated into the BD BACTEC Plus Anaerobic/F blood culture medium vial, which is inserted into the BD BACTEC Fluorescent Series instrument for incubation, agitation and periodic measurement. When microorganisms are present in the blood sample, they metabolize nutrients in the culture medium, releasing CO₂ into the medium. A dye in the sensor reacts with the CO₂, modulating the amount of light that is absorbed by the fluorescent material in the sensor. The instrument's photo detectors monitor the sensor every 10 minutes and measure the level of fluorescence, which is proportional to the amount of CO₂ present in the vial. Positivity of a vial is determined by algorithms resident in the instrument rack's microprocessor. The algorithms use the rate of CO₂ production as well as the absolute increase in CO₂ to interpret the data.
Culture vials flagged as presumptively positive are removed from the instrument for subculture and Gram stain in order to identify the microorganisms for further evaluation and proposed patient treatment. Culture vials that are not flagged as positive remain in the instrument until the test protocol has been completed and negative bottles are discarded at the end of protocol (120 hours).
M. Performance Characteristics (if/when applicable):
1. Analytical performance:
a. Precision/Reproducibility:
The BACTEC Plus Anaerobic/F (Plastic) vial was evaluated across three lots in the Time To Detection and the Percent Recovery (Sensitivity) studies. For study details, please see section 1.d and 2.a below. Different lots of key raw materials were used to manufacture each lot of culture media. The results stratified by lot (combining blood volumes, inoculum levels, organisms, and instruments) are shown in Table 1. The precision data for the 10-100 CFU inoculum levels stratified by instrument type (combining blood volumes, organisms, and lots) are shown in Table 2.
{4}
Table 1: Precision data by lot- positive percent and median Time to Detection (TTD)
| Plastic lot | Percent of results positive | Median TTD (hours) |
| --- | --- | --- |
| 3220225 | 78.21% | 13.2922 |
| 3220228 | 78.21% | 12.8469 |
| 3220230 | 80.71% | 13.4590 |
The lot-to-lot difference results were:
- Percent of samples with positive results by all three lots $= 72.86\%$
- Percent of samples with positive results only by two lots $= 5.00\%$
- Percent of samples with positive results only by one lot $= 8.57\%$
- Percent samples with negative results by all three lots $= 13.57\%$
The analysis was acceptable and there was no statistically significant difference across the lots in the precision study.
Table 2: Precision data by instrument (10-100 CFU) - positive percent and median Time to Detection (TTD) in hours
| Instrument | Percent of results positive | Median TTD (hours) |
| --- | --- | --- |
| 9050 | 85.61% | 13.5003 |
| 9240 | 87.88% | 13.4189 |
| FX | 85.61% | 13.4597 |
| FX 40 | 86.36% | 14.7321 |
The analysis for different instruments was also evaluated at 10-100 CFU with the following results:
- Percent of samples with positive results by all four instruments $= 80.91\%$
- Percent of samples with positive results only by three instruments $= 6.11\%$
- Percent of samples with positive results only by two instruments $= 1.53\%$
- Percent of samples with positive results only by one instrument $= 0.00\%$
- Percent of samples with negative results by all four instruments $= 11.45\%$
The analysis was acceptable and there was no statistical significant difference among the four instruments.
b. Linearity/assay reportable range:
Not applicable
{5}
c. Traceability, Stability, Expected values (controls, calibrators, or methods):
## Quality Control
An internal validation study across three lots with inoculum of <100 CFU/vial was conducted using the organisms listed below. *Clostridium perfringens* and *Bacteroides fragilis* were evaluated with nine vials each; *S. pneumoniae*, *E. coli*, *Bacteroides vulgatus*, and *S. aureus* were evaluated with eight vials each. *Clostridium histolyticum* was evaluated in the Time to Detection study of 24 replicates. All the following organisms were detected ≤72 hours:
- *Clostridium histolyticum* ATCC 19401
- *Clostridium perfringens* ATCC 13124
- *Streptococcus pneumoniae* ATCC 6305
- *Bacteroides fragilis* *ATCC 25285*
- *E. coli* ATCC 25922
- *Bacteroides vulgatus* ATCC 8482
- *Staphylococcus aureus* ATCC 25923
*CLSI recommended strain
d. Detection limit:
## Microbial Detection Limit (target inoculum level 0-1, 1-10 CFU/vial)
The microbial detection limit study was conducted to assess the capability of the culture media to detect low numbers of organisms (expected target level of 0-1 and 1-10 CFU/vial) when present in blood. The study included 13 organisms (six anaerobes and seven facultative anaerobes) tested at two blood volumes, each at challenging target inoculum levels of 0-1 and 1-10 CFU/vial across three lots with BACTEC FX and BACTEC 9240:
- 13 organisms x 2 blood vol. x 2 inoculum vol. x 3 lots x 2 instrument types = 312
The results stratified by organism (combining blood volumes, inoculum levels, lots and instruments) are shown in Table 3. The results stratified by inoculum level (combining organisms, blood volumes, lots and instruments) are shown in Table 4.
6
{6}
Table 3: Microbial Detection Limit difference by organism
| Organism name | Number of samples | Percent recovery for Plastic | Percent recovery for Glass | Difference between percent recovery of Plastic and Glass | 95% CI lower-bound | 95% CI upper-bound |
| --- | --- | --- | --- | --- | --- | --- |
| Bacteroides fragilis | 24 | 58.33% | 37.50% | 20.83% | 0.90% | 40.77% |
| Bacteroides vulgatus | 24 | 70.83% | 62.50% | 8.33% | -17.28% | 33.94% |
| Clostridium perfringens | 24 | 37.50% | 45.83% | -8.33% | -31.19% | 14.52% |
| Enterococcus faecalis | 24 | 79.17% | 66.67% | 12.50% | -8.52% | 33.52% |
| Escherichia coli | 24 | 75.00% | 75.00% | 0.00% | -20.00% | 20.00% |
| Fusobacterium nucleatum | 24 | 50.00% | 33.33% | 16.67% | -5.45% | 38.78% |
| Porphyromonas asaccharolytica | 24 | 54.17% | 54.17% | 0.00% | -20.00% | 20.00% |
| Staphylococcus aureus | 24 | 58.33% | 79.17% | -20.84% | -40.77% | -0.90% |
| Staphylococcus epidermidis | 24 | 62.50% | 54.17% | 8.33% | -7.66% | 24.32% |
| Streptococcus agalactiae (Strep. group B) | 24 | 83.33% | 66.67% | 16.66% | -5.45% | 38.78% |
| Streptococcus pneumoniae | 24 | 75.00% | 62.50% | 12.50% | -14.12% | 39.12% |
| Streptococcus pyogenes (Strep. group A) | 24 | 70.83% | 79.17% | -8.34% | -33.94% | 17.28% |
| Veillonella parvula | 24 | 91.67% | 45.83% | 45.84% | 20.06% | 71.60% |
{7}
Table 4: Microbial Detection Limit (target level 0-1, 1-10 CFU/vial) difference by CFU level
| CFU | Number of samples | Percent recovery for Plastic | Percent recovery for Glass | Difference between percent recovery of Plastic and Glass | 95% CI lower-bound | 95% CI upper-bound |
| --- | --- | --- | --- | --- | --- | --- |
| 0-1 | 180 | 48.33% | 37.22% | 11.11% | 2.16% | 19.78% |
| 1-10 | 132 | 91.67% | 87.88% | 3.79% | -2.30% | 9.88% |
In summary, the study did not support the claim for target inoculum levels of 0-1 or 1-10 CFU/vial for either type of vials because the percent recovery was less than 50% at 0-1 CFU/vial, and less than 95% for plastic and 90% for glass vials at target level of 1-10 CFU/vial. Because of the risk associated with bloodstream infections, the expected percent recovery is close to 100% for blood culture devices. Therefore, the claim for the BD BACTEC Plus Anaerobic /F (plastic) was 10-100 CFU/vial as demonstrated in the Percent Recovery study below (Tables 7, 8, and 9).
e. Analytical specificity:
Not applicable
f. Assay cut-off:
Not applicable
2. Comparison studies:
Performance of the BD BACTEC Plus Anaerobic/F (plastic) blood culture vials was evaluated in a seeded internal analytical studies to demonstrate comparable performance to the predicate device, the BD BACTEC Plus Anaerobic/F (glass) blood culture vials. Comparison results were acceptable. The comparisons were made using the following parameters: Time to detection, percent recovery, false negative rate, false positive rate, and antimicrobial neutralization capability.
For comparison of time to detection, percent recovery, and false negative rate studies, 95% two-sided bootstrap confidence intervals for differences were used for the statistical analysis.
a. Method comparison with predicate device:
Instrument Time to Detection (TTD) study
The TTD analysis was evaluated in the percent recovery study with 442 pairs of both glass positive and plastic positive results at inoculum level of 10-100 CFU/vial, two blood volumes of 3 mL and 10 mL, across three lots and by four instruments. The study demonstrated the following:
{8}
i. Plastic vial median TTD: 16.696 hours
ii. Glass vial median TTD: 16.773 hours
iii. Difference in median TTD (Plastic-Glass): -0.0776 hours
The data indicated that the new device (plastic vial) was 4.62 minutes faster than the predicate device (glass vial). The new device performed equivalently when compare to the predicate device.
The data also indicated that the performance for different blood volumes, $3\mathrm{mL}$ and $10\mathrm{mL}$ were the same. The TTD results for the 10-100 CFU inoculum levels stratified by lot (combining blood volumes, organisms, and instruments) are shown in Table 5. The percent recovery results for the 10-100 CFU inoculum levels stratified by instrument type (combining blood volumes, organisms, and lots) are shown in Table 6 below.
Table 5: Time to Detection (10-100 CFU/vial) by lot, 442 paired-positive sets
| Lot | Plastic median TTD | Glass median TTD | TTD difference (Plastic – Glass) | 95% CI lower-bound | 95% CI upper-bound |
| --- | --- | --- | --- | --- | --- |
| 3220225 | 16.6957 | 16.7013 | -0.0056 | -3.2951 | 1.1672 |
| 3220228 | 16.8592 | 16.7410 | 0.1182 | -1.6702 | 1.3393 |
| 3220230 | 16.4622 | 17.4513 | -0.9890 | -2.5551 | 0.1913 |
Table 6: Time to Detection (10-100 CFU/vial) by instrument, 442 paired-positive sets
| Instrument | Plastic median TTD | Glass median TTD | TTD difference (Plastic – Glass) | 95% CI lower-bound | 95% CI upper-bound |
| --- | --- | --- | --- | --- | --- |
| 9050 | 15.4167 | 16.8335 | -1.4168 | -2.0023 | 1.1686 |
| 9240 | 17.7356 | 20.3581 | -2.6225 | -2.9709 | 0.5024 |
| FX | 15.7833 | 16.0383 | -0.2550 | -1.9952 | 0.2169 |
| FX 40 | 17.7321 | 17.4788 | 0.2533 | -2.0055 | 1.1128 |
# Percent Recovery study
The percent recovery was evaluated in a study of 528 paired sets at the inoculum of 10- 100 CFU/vial on four instruments across three lots using a diverse set of microorganisms frequently isolated in blood. Of the 528 paired sets, 442 sets recovered organisms in both the plastic vial and the glass vial and 70 were negative by both vials. Fourteen paired sets were recovered in the plastic vials but not in the glass vials and two were recovered in the glass vials but not in the plastic vials. Petptostreptococcus anaerobius and Finegoldia magna (formerly Peptostreptococcus
{9}
magnus) were not recovered in the plastic or glass vials (Table 7). Peptoniphilus asaccharolyticus was recovered at the rate of 29% in plastic but 12% in glass. These organism groups were included in the limitation section of the package insert (PI). The organisms recovered at lower than 95% in plastic were Bacteroides fragilis and Fusobacterium nucleatum and were noted in the performance characteristics of the PI.
The percent recovery results for the 10-100 CFU inoculum levels stratified by organism (combining blood volumes, lots, and instruments) are shown in Table 7. The percent recovery results for the 10-100 CFU inoculum levels stratified by lot (combining blood volumes, organisms, and instruments) are shown in Table 8 below. The results demonstrated no significant difference between the plastic vials and the glass vials.
Table 7: Percent Recovery (10-100 CFU/vial) difference by organism
| Organism name | Number of samples | Percent recovery for Plastic | Percent recovery for Glass | Difference between percent recovery of Plastic and Glass | 95% CI lower-bound | 95% CI upper-bound |
| --- | --- | --- | --- | --- | --- | --- |
| Bacteroides fragilis | 24 | 92% | 92% | 0% | -16% | 16% |
| Bacteroides ovatus | 24 | 100% | 100% | 0% | -12% | 12% |
| Bacteroides thetaiotaomicron | 24 | 100% | 100% | 0% | -12% | 12% |
| Bacteroides vulgatus | 24 | 100% | 100% | 0% | -12% | 12% |
| Clostridium histolyticum | 24 | 100% | 96% | 4% | -10% | 18% |
| Clostridium novyi | 24 | 96% | 88% | 8% | -8% | 24% |
| Clostridium perfringens | 24 | 100% | 100% | 0% | -12% | 12% |
| Enterococcus faecalis | 24 | 100% | 100% | 0% | -12% | 12% |
| Enterococcus faecium | 24 | 100% | 100% | 0% | -12% | 12% |
| Escherichia coli | 24 | 100% | 100% | 0% | -12% | 12% |
| Finegoldia magna | 24 | 0% | 0% | 0% | -12% | 12% |
| Fusobacterium nucleatum | 24 | 83% | 79% | 4% | -14% | 22% |
{10}
| Organism name | Number of samples | Percent recovery for Plastic | Percent recovery for Glass | Difference between percent recovery of Plastic and Glass | 95% CI lower-bound | 95% CI upper-bound |
| --- | --- | --- | --- | --- | --- | --- |
| Klebsiella pneumoniae ssp pneumoniae | 24 | 100% | 100% | 0% | -12% | 12% |
| Peptoniphilus asaccharolyticus | 24 | 29% | 12% | 17% | -2% | 36% |
| Peptostreptococcus anaerobius | 24 | 0% | 0% | 0% | -12% | 12% |
| Porphyromonas asaccharolytica | 24 | 100% | 100% | 0% | -12% | 12% |
| Staphylococcus aureus | 24 | 100% | 100% | 0% | -12% | 12% |
| Staphylococcus epidermidis | 24 | 100% | 100% | 0% | -12% | 12% |
| Streptococcus agalactiae (Strep. group B) | 24 | 100% | 100% | 0% | -12% | 12% |
| Streptococcus pneumoniae | 24 | 100% | 100% | 0% | -12% | 12% |
| Streptococcus pyogenes (Strep. group A) | 24 | 100% | 100% | 0% | -12% | 12% |
| Veillonella parvula | 24 | 100% | 83% | 17% | -2% | 36% |
Table 8: Percent Recovery (10-100 CFU/vial) summary table by lot
| Lot | Number of samples | Percent recovery for Plastic | Percent recovery for Glass | Difference between percent recovery of Plastic and Glass | 95% CI lower-bound | 95% CI upper-bound |
| --- | --- | --- | --- | --- | --- | --- |
| 3220225 | 176 | 86% | 85% | 1 | -2% | 4% |
| 3220228 | 176 | 86% | 84% | 2 | 0% | 5% |
| 3220230 | 176 | 86% | 83% | 3 | 0% | 7% |
{11}
12
# False Positive Rates
False positivity was assessed with vials inoculated with fresh human blood of 2, 4, 6, and 8 mL, but no organisms were added to the vials. There were 240 pair sets across three lots using BACTEC FX and BACTEC 9240. The false positive rate was 0.42% (1/240) for the glass vials and 0% (0/240) for plastic vials. These results demonstrated no significant difference between the plastic vials and the glass vials.
# False Negative Rates (Instrument-negative, subculture positive)
A false negative is a vial that was instrument-negative at the end of protocol (120 hours) yet contains viable organisms upon subculturing onto appropriate culture media. There were a total of 146 paired sets where both the new and the predicate devices were negative at 120 hours; there were 30 sets where the predicate device only detected (i.e. 30 plastic vials subcultured) and 67 vials where the new device detected (i.e. 67 glass vials subcultured)
(146 x 2) +30 +67 = 389
Of the 389 instrument-negative vials, 16 were subculture positive; two were from the plastic vials while 14 were from the predicate (glass) vials. The two false negative from the plastic device were *Peptoniphilus asaccharolyticus* at inoculum level of 10-100 CFU/vial, and *Porphyromonas ascharylytica* (formerly *Bacteroides melaninogenicus* subspp. *asaccharolyticus*) at inoculum level of 0-1 CFU/vial.
The false negative of *Peptoniphilus asaccharolyticus* and *Porphyromonas ascharylytica* were included in the limitation and performance characteristics sections of the PI respectively. These results demonstrated no significant difference between the plastic vials and the glass vials.
# BACTEC Instrument Compatibility
A total of 132 paired sets at 10-100 CFU/vial were evaluated across four instruments comprising of BACTEC 9050, 9240, FX, and FX40 in the percent recovery study. Twenty-two organisms were evaluated with both 3 mL and 10 mL blood. The performance for different blood volumes, 3 mL and 10 mL, were the same.
The percent recovery results for the 10-100 CFU inoculum levels stratified by instrument (combining organisms, blood volumes, and lots are shown in Table 9. These results demonstrated no significant difference between the plastic vials and the glass vials.
22 organisms x 2 blood vol. x 3 lots = 132
132 x 4 instruments = 528
{12}
Table 9: Percent Recovery (10-100 CFU/vial) summary table by instrument
| Instrument | Number of samples | Percent recovery for Plastic | Percent recovery for Glass | Difference between percent recovery of Plastic and Glass | 95% CI lower-bound | 95% CI upper-bound |
| --- | --- | --- | --- | --- | --- | --- |
| 9050 | 132 | 86% | 83% | 3% | -1% | 7 |
| 9240 | 132 | 88% | 86% | 2% | -2% | 5 |
| FX | 132 | 86% | 83% | 3% | -1% | 7 |
| FX40 | 132 | 86% | 85% | 2% | -1% | 4 |
## Antimicrobial Neutralization Capability
The study was to demonstrate the nonionic and cationic resins in the culture media to enhance the recovery of anaerobes by adsorption of commonly used antibiotics in the blood samples. The antibiotics evaluated were Ciprofloxacin, Cefazolin, Cefotaxime, Cefepime, Cefoxitin, Clindamycin, Gentamicin, Meropenem, Metronidazole, Piperacillin/Tazobactam and Vancomycin.
The study included testing for anaerobes in which each tested anaerobe was susceptible to the antibiotic concentration inoculated into the culture vial at 10-100 CFU/vial, 7 mL of blood and across three lots by BACTEC FX. Meropenem susceptible *Clostridium perfringens* was not recovered in glass or plastic vials, across three lots when tested at susceptible MIC level in the vials. The result is noted in the performance characteristics section of the PI. The performance is listed in Table 10 below. These results demonstrated no significant difference between the plastic vials and the glass vials.
Table 10: Antibiotics/Anaerobes recovery pair comparison summary
| New Device | Predicate Device | | | |
| --- | --- | --- | --- | --- |
| | Detected | Not Detected | Total | |
| New Device | Detected | 27 | 0 | 27 |
| | Not Detected | 0 | 3 | 3 |
| Total | 27 | 3 | 30 | |
Another study was conducted with facultative anaerobic organisms and the results were noted in Table 11 below. The performance was acceptable; the result obtained with *Staphylococcus aureus* and meropenem was also included in the performance characteristics section of the PI.
{13}
Table 11: Antibiotics/facultative Anaerobes recovery pair comparison summary
| | Predicate Device | | | |
| --- | --- | --- | --- | --- |
| | | Detected | Not Detected | Total |
| New Device | Detected | 59 | 0 | 59 |
| | Not Detected | 1* | 0 | 1 |
| | Total | 60 | 0 | 60 |
* Staphylococcus aureus with meropenem
b. Matrix comparison:
BD BACTEC Plus Anaerobic/F culture medium, human blood volume, common blood bloodstream pathogens (anaerobes and facultative anaerobes) by BACTEC FX, FX40, BACTEC 9240, and BACTEC 9050.
3. Clinical studies:
Not applicable; seeded analytical studies to compare the new plastic blood culture vials to the glass blood culture vials (predicate).
a. Clinical Sensitivity:
Not applicable
b. Clinical specificity:
Not applicable
c. Other clinical supportive data (when a. and b. are not applicable):
Not applicable
4. Clinical cut-off:
Not applicable
5. Expected values/Reference range:
Seeded analytical studies demonstrated equivalent performance of the BD BACTEC Plus Anaerobic/F (plastic) blood culture medium when compared to the BD BACTEC Plus Anaerobic/F (glass) blood culture medium.
{14}
15
N. Instrument Name:
BACTEC FX, FX40, BACTEC 9240, and BACTEC 9050
O. System Descriptions:
1. Modes of Operation:
BACTEC Plus Anaerobic/F culture bottles are for use with the BACTEC 9000 series, BACTEC FX, and BACTEC FX40 instruments. The BACTEC blood culture system is an automated microbiology growth and detection system designed to detect microbial growth from blood specimens. When microorganisms are present in culture vials, they metabolize nutrients in the culture medium, releasing carbon dioxide into the medium. A dye in the sensor at the bottom of the vial reacts with CO₂ which modulates the amount of light that is absorbed by a fluorescent material in the sensor. A photo detector at each station measures the level of fluorescence, which corresponds to the amount of CO₂ released by organisms.
2. Software:
FDA has reviewed applicant’s Hazard Analysis and software development processes for this line of product types:
Yes ☐ X ☐ or No ☐
3. Specimen Identification:
Sample ID can be entered via a barcode reader or by manual entry with an onscreen keyboard.
4. Specimen Sampling and Handling:
Automated sample handling
5. Calibration:
Not applicable
6. Quality Control:
Refer to section M 1.c above for culture media quality control
P. Proposed Labeling:
The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.
{15}
Q. Conclusion:
The submitted information in this premarket notification is complete and supports a substantial equivalence decision.
16
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.
Copy this now. It will not be shown again.
Connected apps
Apps you authorized through browser sign-in. Disconnecting revokes their access immediately.
Learn the FDA Browser
Two short videos show you everything — or skip straight to the written tutorial if you'd rather read. You can reopen this any time from the Tutorial button in the top bar.
Part 1 — Search, results, and everyday workflows 16 min
Part 2 — Embeddings: the galaxy map 3 min
1. Search: exact and fuzzy
Type a phrase like "coronary artery calcification" into the search box. You get two kinds of results. Exact results match the literal phrase — prefix searches work ("coronary artery calcificati") but suffix searches do not. Fuzzy results match on the meaning and intent of your phrase rather than the exact words, and are sorted by relevance score. Hover over the Exact or Fuzzy badge on any row to see exactly why it matched.
Use the checkboxes above the results to narrow: SaMD keeps only software-only devices, AI / ML keeps only devices with AI.
Exact vs. fuzzy search: what's the difference?
Exact matches on the literal phrase (prefix search works, suffix does not). Fuzzy matches on the meaning and intent of the phrase rather than the exact words. Hover over the badge on any row to see why it matched.
You search "coronary artery calcification" and want only software devices with AI. What two filters do you apply?
Narrow by SaMD (software-only devices), then narrow by AI/ML (devices with AI).
2. The results table
Scroll right in the results table. The intended use is extracted for you — no need to open the PDF. The device story gives a high-level snapshot of what the device does and how it's used. The AI Performance sub-table shows each output name, acceptance criteria, observed values, and development/test dataset descriptions — the same format Innolitics uses for regulatory strategy outputs, and the fastest high-level fingerprint of an AI device. It is AI-generated but has been very reliable in practice.
Where do you find a device's intended use without opening the PDF?
Scroll right in the search results table. The intended use column is extracted for you; no need to dig into the 510(k) summary PDF.
What does the AI Performance sub-table show, and why is it useful?
Output name, acceptance criteria, observed values, development dataset description, and test dataset description. It's the same format we use for regulatory strategy output and Fast 510(k) input, and the fastest high-level fingerprint of an AI device. AI-generated but reliable in practice.
3. Judging fuzzy relevance
Fuzzy results trail off in relevance as you scroll. Use three signals to decide how far down to go: the fuzzy badge explanations, the intended use column, and whether your target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, you're past the relevant zone. A top hit with a low score (~0.4) and a stretched explanation is a hint the closest predicates are far away — the project may be headed for De Novo. Note the fuzzy search is a pattern match: it doesn't handle negation ("not") well, and hardware devices can appear — filter by SaMD/AI ML to cut them.
How do you judge how far down fuzzy search results to go?
Use the relevancy signals: the fuzzy badge explanations, the intended use column, and whether the target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, results are trailing off in relevancy.
4. Device detail page: chat and citations
Click a device name to open its detail page: device facts on the left, a chat window on the right. Ask something like "Describe the training data". The answer carries little citation bubbles — click one to jump to the highlighted passage in the source PDF, so you can verify every AI answer against the document. There's also a Download PDF button for sharing.
How do you verify an AI chat answer on the device detail page?
Click the citation bubbles to jump to the relevant highlight in the source document.
Reading rule for every project: how many summaries do you read in full?
At least the three most relevant 510(k) or De Novo summaries, in full. After that, use targeted chat questions to confirm your memory quickly. The tool supports this professional habit — it doesn't replace it.
5. Side-by-side comparison
Select multiple rows in the results table (aim for under ~10), then open the PDF Viewer tab. Ask one question — it goes to all selected devices in parallel, each with citations. This is the fastest way to compare and contrast devices: training data, PCCP scope, how they handled adding new scanners, and so on.
What does the side-by-side PDF viewer mode do?
Select multiple devices, open the PDF viewer tab, and ask one question (e.g., "Describe the training data"). It queries all selected devices simultaneously with citations, so you can compare and contrast quickly.
6. Collections
With rows selected, go to the Collections tab and create a labeled collection (e.g., "Cobb Angle Project"). Reload that selection any time — before a client call, pull up the collection and ask questions across all of its devices at once.
How do you save a set of selected devices for later use?
Select the rows, go to the Collections tab, and create a labeled collection (e.g., "Cobb Angle Project"). You can reload the selection anytime and carry it into the PDF viewer and other tabs that support selections.
7. Product codes and the regulations tree
Click a product code in the results to jump to it in the regulations tree — identification text, sibling product codes, and devices you can open in a PDF viewer on the right. Click a regulation number to see its identification, special controls, and related product codes. You can also search by product code or regulation number at the top of the tree. Always read the special controls if any exist for your device — it broadens your search and sharpens pre-kickoff research.
What can you do from the regulations tree view?
Browse product codes and regulation numbers, read the identification text and special controls, browse sibling product codes, open device PDFs on the right, and search by product code or regulation number at the top of the tree.
8. Chart view
Click Show Chart and segment by regulation number (or product code) to see which regulations dominate your result set. Clicking a regulation takes you into the regulations tree. Great for spotting that most matches are, say, hardware laparoscopic devices — a cue to go back and filter.
How do you see which regulations dominate a search result set?
Click "Show Chart" and segment by Regulation Number. Clicking a regulation takes you to the regulations tree.
9. The predicate graph
Open the Predicates tab for a family-tree view of predicate relationships. Click a node to trace its parents and children; selections from search carry over pre-selected. Commonly predicated devices are worth reading — a lot of people predicated them for a reason. The visual lineage is also handy on client calls, e.g. to show how a predicate family evolved and justify why your predicate still holds.
In the predicate graph, why are commonly predicated devices worth reading?
A lot of people predicated them for a reason. Clicking a node traces parents and children, and selections from search carry over pre-selected.
10. Embeddings: the galaxy map
The Embeddings tab plots every matching document in a 2-D "galaxy map" where semantically similar devices cluster together. Hover or click clusters to explore, and let AI label the clusters for you. Embeddings beat product codes for grouping: two devices can carry different product codes (LLZ vs. QIH) yet do the same thing — the embedding captures the meaning of the intended use and device story. This is also exactly how retrieval-augmented generation (RAG) works under the hood, and it makes a great visual on client calls.
Try it yourself
Head to the search page and work through a few of these AI/ML fuzzy searches to build intuition: perivascular fat on CT · aortic valve calcification opportunistic screening on noncontrast CT · breast cancer prediction on digital pathology slides · autism detection · gestational age prediction · a hearing aid that can also detect a pulse · foundation model based analysis of ECG · large language models · penetration test. Watch how the relevance scores, intended use, and AI Performance tables tell you when results stop being meaningful.